Founded in 2006 and based in Athens, IGIASI S.A. specializes in the marketing and distribution of advanced medical technologies from internationally recognized manufacturers. Through its collaboration with AVITA Medical, IGIASI is the exclusive representative of RECELL™ in Greece, supporting the introduction and clinical use of this innovative regenerative technology.
AVITA Medical is a regenerative medicine company focused on wound healing and skin restoration. Its RECELL™ System is a point-of-care technology that uses a small sample of the patient’s own skin to prepare an autologous skin cell suspension containing keratinocytes, fibroblasts and melanocytes, supporting re-epithelialization and skin regeneration.
RECELL is FDA premarket-approved in the United States, while in Europe the RECELL GO™ Autologous Cell Harvesting Device is CE marked under the European Union Medical Device Regulation, reflecting its established regulatory status across major international markets.


